BioCentury | Nov 10, 2017
Financial News

NEA, Versant back ophthalmic play Oyster Point with $22M A round

...medical affairs at Ophthotech Corp. (NASDAQ:OPHT). Two other members of the company’s leadership hail from Oculeve Inc....
...medical device company, while CFO Mark Murray was CFO. Versant and NEA both invested in Oculeve...
BioCentury | Nov 7, 2017
Financial News

NEA, Versant back ophthalmic play Oyster Point with $22M A round

...medical affairs at Ophthotech Corp. (NASDAQ:OPHT). Two other members of the company’s leadership hail from Oculeve Inc....
...medical device company, while CFO Mark Murray was CFO. Versant and NEA both invested in Oculeve. Elizabeth...
BioCentury | Aug 17, 2015
Company News

Oculeve, Allergan deal

...Allergan will acquire ophthalmic medical device company Oculeve for $125 million in cash. Oculeve is eligible...
...2016, with a potential commercial launch in 2017. The deal is expected to close 3Q15. Oculeve Inc....
Items per page:
1 - 3 of 3
BioCentury | Nov 10, 2017
Financial News

NEA, Versant back ophthalmic play Oyster Point with $22M A round

...medical affairs at Ophthotech Corp. (NASDAQ:OPHT). Two other members of the company’s leadership hail from Oculeve Inc....
...medical device company, while CFO Mark Murray was CFO. Versant and NEA both invested in Oculeve...
BioCentury | Nov 7, 2017
Financial News

NEA, Versant back ophthalmic play Oyster Point with $22M A round

...medical affairs at Ophthotech Corp. (NASDAQ:OPHT). Two other members of the company’s leadership hail from Oculeve Inc....
...medical device company, while CFO Mark Murray was CFO. Versant and NEA both invested in Oculeve. Elizabeth...
BioCentury | Aug 17, 2015
Company News

Oculeve, Allergan deal

...Allergan will acquire ophthalmic medical device company Oculeve for $125 million in cash. Oculeve is eligible...
...2016, with a potential commercial launch in 2017. The deal is expected to close 3Q15. Oculeve Inc....
Items per page:
1 - 3 of 3